|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3049441 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14784169.6 |
| Date of filing the European patent application | 2014-09-26 | |
| (97) | Date of publication of the European application | 2016-08-03 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-27 |
| (46) | Date of publication of the claims translation | 2020-02-10 |
| (86) | Number | PCT/US2014/057821 |
| Date | 2014-09-26 |
| (87) | Number | WO 2015/048520 |
| Date | 2015-04-02 |
| (30) | Number | Date | Country code |
| 201361883953 P | 2013-09-27 | US |
| (72) |
YANG, Ying, US
ALAVATTAM, Sreedhara, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Anti-PDL1 antikūnų kompozicija |
| ANTI-PDL1 ANTIBODY FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2024-08-20 | 11 | 289.00 EUR |
| 2025-09-26 |